ADAGE CAPITAL PARTNERS GP, L.L.C. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2018$21,912,000
-90.0%
322,000
-85.5%
0.05%
-89.7%
Q4 2017$219,694,000
-28.1%
2,222,500
-12.8%
0.50%
-33.0%
Q3 2017$305,363,000
+4.3%
2,550,000
-23.9%
0.74%
+3.6%
Q2 2017$292,790,000
+38.4%
3,350,000
-41.1%
0.72%
+34.3%
Q1 2017$211,544,000
+21.2%
5,686,6680.0%0.53%
+11.7%
Q4 2016$174,581,000
-54.2%
5,686,6680.0%0.48%
-54.6%
Q3 2016$381,291,000
+125.1%
5,686,6680.0%1.05%
+127.3%
Q2 2016$169,406,000
+1.4%
5,686,6680.0%0.46%
+2.0%
Q1 2016$167,017,000
-62.5%
5,686,6680.0%0.45%
-61.2%
Q4 2015$445,835,000
+4.0%
5,686,6680.0%1.17%
-1.8%
Q3 2015$428,527,000
-35.5%
5,686,6680.0%1.19%
-28.2%
Q2 2015$663,918,000
-50.6%
5,686,6680.0%1.66%
-49.4%
Q1 2015$1,342,679,000
+24.7%
5,686,6680.0%3.27%
+24.3%
Q4 2014$1,076,316,000
-20.7%
5,686,6680.0%2.63%
-21.4%
Q3 2014$1,356,668,000
+261.5%
5,686,6680.0%3.35%
+245.6%
Q2 2014$375,320,000
-36.6%
5,686,6680.0%0.97%
-40.0%
Q1 2014$592,210,000
+0.6%
5,686,6680.0%1.62%
+3.7%
Q4 2013$588,741,000
+109.3%
5,686,668
+8.5%
1.56%
+92.7%
Q3 2013$281,314,000
+20.9%
5,242,5190.0%0.81%
+12.8%
Q2 2013$232,611,000
+32.9%
5,242,5190.0%0.72%
+24.0%
Q1 2013$175,048,0005,242,5190.58%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders